Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. Dezember 2019 08:10 ET | Quelle: Exagen, Inc.

National Experts in Autoimmunity Tapped to Serve on Exagen’s Scientific Advisory Board

SAN DIEGO, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
22. November 2019 08:25 ET | Quelle: Exagen, Inc.

Exagen extends agreement with GSK for a third year to drive greater awareness about challenges facing lupus diagnosis and management

SAN DIEGO, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
21. November 2019 08:25 ET | Quelle: Exagen, Inc.

Exagen Inc. Announces $26.2 Million Debt Refinancing

SAN DIEGO, Calif., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
20. November 2019 05:15 ET | Quelle: Exagen, Inc.

Exagen Inc. to Participate in the 31st Annual Piper Jaffray Healthcare Conference on December 5, 2019

SAN DIEGO, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
28. Oktober 2019 08:15 ET | Quelle: Exagen, Inc.

Exagen Featured in Nine Scientific Presentations at 2019 ACR/ARHP Annual Meeting in Atlanta

SAN DIEGO, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
21. Oktober 2019 08:15 ET | Quelle: Exagen, Inc.

Exagen to Be Honored with National Research Innovation Award by Lupus Foundation of America

SAN DIEGO, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
15. Oktober 2019 08:15 ET | Quelle: Exagen, Inc.

Exagen Announces Publication of Two Key Studies Validating Clinical Performance of AVISE® Lupus in Patients with Probable SLE and Demonstrating Superior Clinical Utility Compared to Standard Diagnostic Testing

SAN DIEGO, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
19. August 2019 08:57 ET | Quelle: Exagen Inc.

Exagen and the University of Washington Collaborate on Lupus and Rheumatoid Arthritis Research

San Diego, CA and Albuquerque, NM, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
24. April 2019 09:55 ET | Quelle: Exagen Diagnostics, Inc.

New Biomarker Available to Offer Insight into Thrombosis for Lupus Sufferers

San Diego, CA and Albuquerque, NM, April 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., a leader in helping rheumatologist and their patients in the diagnosis, prognosis, and management of chronic...
26. März 2019 08:45 ET | Quelle: Exagen Diagnostics, Inc.

JEFFREY THOMAS ELLIOTT, CFA Joins Exagen’s Board of Directors

San Diego, CA and Albuquerque, NM, March 26, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...

Nächste Seite